Tenon Medical Income Statement (2021-2025) | TNON

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.01M0.02M0.07M0.05M0.07M0.14M0.21M0.28M0.43M0.74M0.94M0.81M0.72M0.90M0.89M0.77M0.73M0.56M1.17M
Cost of Revenue 0.01M0.91M0.56M0.67M0.28M1.94M0.65M4.60M2.03M1.88M1.53M1.34M1.38M1.45M1.21M1.07M1.65M1.12M1.54M
Gross Profit 0.00M0.01M0.05M0.04M-0.20M-0.14M-0.09M-0.21M-0.05M0.19M0.54M0.56M0.47M0.47M0.42M0.35M0.32M0.24M0.77M
Operating items
Research & Development 0.09M0.24M0.60M0.79M0.56M0.66M0.80M0.81M0.83M0.90M0.74M0.69M0.67M0.71M0.66M0.57M0.69M0.50M0.43M
Selling, General & Administrative 0.10M0.48M0.99M1.14M1.04M2.72M1.73M1.94M1.98M1.73M1.65M1.67M1.93M2.19M1.76M1.89M1.66M1.48M2.20M
Other Operating Expenses 0.00M0.91M0.56M0.67M0.28M1.94M0.65M4.97M2.03M1.88M1.53M1.34M1.38M1.45M1.21M1.07M1.65M1.12M1.54M
Operating Expenses 0.19M1.63M2.15M2.60M1.88M5.32M3.17M7.72M4.84M4.52M3.91M3.70M3.98M4.34M3.63M3.53M4.00M3.10M4.17M
Operating Income -0.19M-1.61M-2.10M-2.56M-2.08M-5.46M-3.26M-7.93M-4.89M-4.32M-3.38M-3.14M-3.51M-3.87M-3.21M-3.17M-3.68M-2.86M-3.39M
EBIT -0.19M-1.61M-2.10M-2.56M-2.08M-5.46M-3.26M-7.93M-4.89M-4.32M-3.38M-3.14M-3.51M-3.87M-3.21M-3.17M-3.68M-2.86M-3.39M
Non-operating items
Non Operating Investment Income 0.00M0.00M0.00M0.04M0.07M0.07M0.06M0.04M0.05M0.02M0.03M0.04M0.03M0.09M0.06M0.09M0.05M
Other Non Operating Income -0.00M0.02M0.02M-0.06M-0.06M0.01M
Non Operating Income -0.01M-0.06M-0.27M-0.28M-0.27M-0.03M0.09M0.02M0.06M0.04M0.05M0.01M-0.07M0.05M0.03M0.15M0.06M0.09M0.05M
Net income details
EBT -0.20M-1.68M-2.36M-2.84M-2.35M-5.54M-3.26M-7.92M-4.89M-4.32M-3.38M-3.16M-3.57M-3.84M-3.21M-3.17M-3.68M-2.86M-3.39M
Profit After Tax -0.20M-1.68M-2.36M-2.84M-2.35M-5.49M-3.17M-7.91M-4.83M-4.29M-3.33M-3.13M-3.58M-3.83M-3.18M-3.09M-3.62M-2.77M-3.34M
Income from Non-Controlling Interests -0.00M-0.01M-0.02M
Income from Continuing Operations -0.20M-1.68M-2.36M-2.84M-2.35M-5.54M-3.26M-7.92M-4.89M-4.32M-3.38M-3.16M-3.57M-3.84M-3.21M-3.17M-3.68M-2.86M-3.39M
Consolidated Net Income -0.20M-1.68M-2.36M-2.84M-2.35M-5.54M-3.26M-7.92M-4.89M-4.32M-3.38M-3.16M-3.57M-3.84M-3.21M-3.17M-3.68M-2.86M-3.39M
Income towards Parent Company -0.20M-1.68M-2.36M-2.84M-2.35M-5.54M-3.26M-7.92M-4.89M-4.32M-3.38M-3.16M-3.57M-3.84M-3.21M-3.17M-3.68M-2.86M-3.39M
Net Income towards Common Stockholders -0.20M-1.68M-2.36M-2.84M-2.35M-5.54M-3.26M-7.92M-4.89M-4.32M-3.38M-3.16M-3.57M-3.84M-3.21M-3.17M-3.68M-2.86M-3.39M
Additional items
EPS (Basic) -0.24-2.01-2.55-2.96-2.38-0.65-2.82-7.71-4.30-3.28-11.69-5.46-10.02-8.16-3.63-0.00M-1.01-0.36-0.40
EPS (Weighted Average and Diluted) -2.01-2.55-2.96-2.38-658.28-0.00M-0.01M-0.00M-0.00M-11.69-5.46-10.02-8.16-3.63-0.00M-1.01-0.36-0.40
Shares Outstanding (Weighted Average) 0.83M842.00919.00903.00990.000.01M0.00M801.000.00M0.00M285.00227.00357.00469.00877.000.00M0.00M0.01M0.01M
Shares Outstanding (Diluted Average) 842.00919.00903.00990.000.01M0.00M801.000.00M0.00M285.00227.00357.00469.00877.000.00M0.00M0.01M0.01M
EBITDA -0.20M-1.68M-2.36M-2.84M-2.35M-5.54M-3.20M-7.84M-4.82M-4.27M-3.36M-3.08M-3.53M-3.83M-3.18M-3.09M-3.62M-2.77M-3.34M
Interest Expenses 0.01M0.06M0.27M0.28M0.27M0.09M-0.01M0.00M0.02M0.06M-0.03M